NEW YORK – Inspirata and Fujifilm today announced that they have formed a partnership that enables Fujifilm to supply Inspirata’s digital pathology products to the National Health Service trusts that provide health services in the UK.
The firms said that their respective technologies are complementary and bridge a technical gap between pathology, radiology, and oncology. They added that the partnership comes at a time when the UK National Health Service is interested in digital pathology's ability to facilitate reduced turnaround times for cancer cases.
In November, the UK invested £50 million ($64 million) to support five new centers to foster the adoption of artificial intelligence in digital pathology.
Financial and other terms of today's deal were not disclosed.
Fujifilm’s team has "a proven record" of delivering, implementing, and servicing national healthcare information technology solutions, Mark Lloyd, Inspirata's executive vice president and cofounder, said in a statement. Bedford, UK-based Fujifilm, a radiology enterprise imaging specialist, is a suitable partner as Inspirata responds to "ever-increasing UK demand for our digital pathology and cancer informatic services," he said.
The partnership allows NHS trusts to choose how they transition to digital pathology and enables them to select only the technologies that are right for them, the firms said. Further, the collaboration provides Inspirata customers with the option to use Fujifilm’s archive, they said.
Tampa, Florida-based Inspirata's UK headquarters is in Hampshire. In June, the firm announced the formation of Inspirata Europe in partnership with Zurich-based Indema.